HMNY = easy money in this range - nice $1+ pop. OPHC broke support and gave a nice entry but needs to move up more now!
OCUL: $4.75 - good entry pt. - just released today: 11/16 insider buy: Sawhney Amarpreet (D) 11/16/2017 P 19,000 A $ 5.18 (1) 696,390
OPHC gave me $8 & might give it again but gonna see if i can catch a little ACST over on $500 Growth account
ACST was moving nice when i was in OPHC but got real boring after logging on over here & may take off in a few but can't trade a/h on this account plus have to get used to taking real small trades which seems like a waste lol. Saw BLMN pop on news -$17's to $21 and maybe i should go with a few more expensive stocks rather than waiting on these little ones to move.... @Neil Allen too many picks here to keep track of so was ACST one of yours b/c if so then maybe it will be safe to swing overnight?
watchlist gainers: XNET: $18.99 + 25%; SIFY: $1.56 + 4%; GELYF: $1.67 + 2%; BORN: $1.33 + 4% (unusual vol.); ACRX: $2.15 + 4%
ACST - missed that one - still focused on China - XNET has gone ballistic; YRD should follow imo... QD is going to trap the shorts soon - it's a screaming buy here @ $18
Late & not playing anything yet but few swings sold (ATOM - DMRC - AAOI - VERI) ACIA missed sell target by 27 cents so still holding for now. KALV a bit bullish today - OCUL double bottom bounce coming up or going lower? @Neil Allen still don't get XNET at all lol & decided not to swing ASCT which was a good thing!!
$500 Growth Account 100 shares GROW @ $3.19 (day trading here but good swing imo & going with more on regular account)
OCUL: $4.45 - good entry pt. - insider buy reported 11/17: Ocular Therapeutix, Inc 1st time Sawhney Amarpreet (Exec. Chairman of the Board) 19,000 5.18 98,420 2017-11-16
Good entry pts: SOHO: $53 - IPI: $3.70 -- QD: $18 -- WIX: $54 -- YRD: $42 -- JP: $20 -- VIPS: $8.26 -- SKYS: $1.53
for some reason my order was not executed which i discovered when i tried to sell @3.40 - have to figure this limit market order stuff out over here for sure b/c pps showing was $3.19 when i bought so no $20+ for me here yet
posted awhile back when you initially posted about this stock that bio hit man brought it down & they have had some manufacturing issues that need to be cleared up so imo is not moving north until company releases news about this plus law suits & needing to raise money etc, etc is not helping this thing @ all & won't be surprised if we see $3's...
Ok this broker is set up a bit differently & i definitely need to spend some time checking this platform out a bit more & wish i had not lucked out with my first order that went south b/c bought that one the same way.
yes, u mentioned the "hit man" - anyway, sticking with it - once they clear up the mess, could be a blockbuster med - "its lead product candidate, DEXTENZA (dexamethasone insert) for intracanalicular use, has completed Phase III clinical development for the treatment of ocular pain and inflammation following ophthalmic surgery. OTX-TP (travoprost insert) is in Phase III clinical development for glaucoma and ocular hypertension"
watchlist gainers: XNET: $21.46 + 13% -- TDOC: $33.60 + 11% -- SQ: $48.06 + 6% -- ZAGG: $23.25 + 6% -- OCLR: $6.86 +6%
